Olanzapine

Teva touts safety profile of once-monthly schizophrenia therapy
Clinical Trials Arena
Mon, 09/23/24 - 11:17 am
Teva Parmceuticals
TEV-749
Olanzapine
schizophrenia
Following in Lilly's footsteps, Teva takes 2nd long-acting schizophrenia drug into phase 3
Fierce Pharma
Tue, 01/31/23 - 12:31 pm
Teva Pharmaceutical
clinical trials
schizophrenia
Eli Lilly
antipsychotics
Olanzapine
TV-44749
FDA flags safety risks for Lilly antipsychotic drug
BioPharma Dive
Tue, 05/10/16 - 03:06 pm
FDA
Eli Lilly
antipsychotics
Symbyax
Zyprexa
Olanzapine
FDA Issues a Complete Response Letter for Lilly's Olanzapine LAI for Treatment of Schizophrenia in Adults
Yahoo
Thu, 01/8/09 - 09:42 am
FDA
Eli Lilly
Olanzapine
schizophrenia